SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 233,364.26 |
| Enterprise Value ($M) | 239,400.96 |
| Book Value ($M) | 47,901.00 |
| Book Value / Share | 27.53 |
| Price / Book | 4.85 |
| NCAV ($M) | -9,231.00 |
| NCAV / Share | -5.31 |
| Price / NCAV | -25.17 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.22 |
| Return on Assets (ROA) | 0.19 |
| Return on Equity (ROE) | 0.35 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.27 |
| Current Ratio | 1.78 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 23,153.00 |
| Assets | 81,448.00 |
| Liabilities | 32,384.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 41,950.00 |
| Operating Income | 7,054.00 |
| Net Income | 13,402.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 8,558.00 |
| Cash from Investing | -2,338.00 |
| Cash from Financing | -5,404.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,031,851 | 3,262,831 | 31.62 | |
| 701,907 | 2,036,649 | 34.46 | |
| 755,783 | 2,511,409 | 30.09 | |
| 631,676 | 4,173,286 | 15.14 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABBV – AbbVie Inc. | ADCT – ADC Therapeutics SA |
| ANRO – Alto Neuroscience, Inc. |